Healthcare & Life Sciences
Kapa Biosystems
United States
acquired
acquired
Stage
About
Kapa Biosystems develops next-generation PCR reagents using molecular evolution technology to optimize enzymes for DNA amplification, next-generation sequencing, and molecular diagnostics.
Explore Kapa Biosystems's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.